442
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Does sugammadex facilitate recovery after outpatient tonsillectomy in children?Footnote

&
Pages 447-450 | Received 28 Mar 2016, Accepted 03 Aug 2016, Published online: 17 May 2019

References

  • R.F.BaughS.M.ArcherR.B.MitchellClinical practice guideline: tonsillectomy in childrenOtolaryngol Head Neck Surg144Suppl. 12011S1S30
  • T.MenckeM.EchternachS.KleinschmidtLaryngeal morbidity and quality of tracheal intubation: a randomized controlled trialAnesthesiology98200310491056
  • M.-Q.ZhangDrug-specific cyclodextrins: the future of rapid neuromuscular block reversalDrugs Future282003347354
  • M.NaguibPharmacology of muscle relaxant and their antagonist neuromuscular physiology and pharmacologyR.D.MillerAnaesthesia6th ed.2006Churchill LivingstonPhiladelphia481572
  • R.K.MirakhurSugammadex in clinical practiceAnaesthesia6420094554
  • I.MakriA.PapadimaA.LafioniatiSugammadex, a promising reversal drug. A review of clinical trialsRev Recent Clin Trials62011250255
  • D.ChambersM.PauldenF.PatonSugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessmentBr J Anaesthesia1052010568575
  • B.PlaudO.MeretojaR.HofmockelReversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patientsAnesthesiology1102009284294
  • B.F.VanackerK.M.VermeyenM.M.R.F.StruysReversal of rocuronium induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevofluraneAnesth Analg1042007563568
  • K.SuyK.MoriasG.CammuEffective reversal of moderate rocuronium-or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agentAnesthesiology1062007283288
  • M.BlobnerL.ErikssonJ.ScholzSugammadex (2.0 mg/kg) significantly faster reverses shallow rocuronium induced neuromuscular blockade compared with neostigmine (50 mg/kg)Eur J Anaesthesiol24Suppl. 392007125 (A9AP7-10)
  • S.J.BrullG.S.MurphyResidual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weaknessAnesth Analg1112010129140
  • O.A.MeretojaNeuromuscular block and current treatment strategies for its reversal in childrenPaediatr Anaesth202010591604
  • I.F.SorgenfreiK.NorrildP.B.LarsenReversal of rocuroniuminduced neuromuscular block by the selective relaxant binding agent sugammadex: dose finding and safety studyAnesthesiology1042006667674
  • S.J.SchallerH.FinkK.UlmSugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular blockAnesthesiology113201010541060
  • R.M.HoggR.K.MirakhurSugammadex: a selective relaxant binding agent for reversal of neuromuscular blockExpert Rev Neurother92009599608
  • T.Fuchs-BuderH.FinkR.HofmockelApplication of neuromuscular monitoring in GermanyAnaesthesist572008908914
  • K.S.Khuenl-BradyM.WattwilB.F.VanackerSugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: multicentre, randomized controlled triadAnesth Analg11020106473
  • R.K.JonesJ.E.CaldwellS.J.BrullReversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmineAnesthesiology1092008816824
  • H.D.de BoerSugammadex: a new challenge in neuromuscular managementAnesth Crit Care2420092025
  • A.AbrishamiJ.HoJ.WongSugammadex: a selective reversal medication for preventing postoperative residual neuromuscular blockadeCochrane Database Syst Rev72009CD007362
  • TurhanKaraOzgurOzbagriacikHacer SebnemTurkSugammadex versus neostigmine in pediatric patients: a prospective randomized studyRev Bras Anestesiol [Internet]6462014 Dec400405 [cited 2016 Jan 16]